HGSNAT and mucopolysaccharidosis type 3C: In the case of Sanfilippo syndrome type C, glucosamine, a competitive HGSNAT inhibitor, has been shown to increase residual enzyme activity in cultured skin fibroblasts from patients affected with a number of missense mutations [24].